Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis

N. de Rouw*, S. Croes, R. Posthuma, D. E. Agterhuis, J. J. A. O. Schoenmaekers, H. J. Derijks, D. M. Burger, A. M. Dingemans, R. ter Heine

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)156-158
Number of pages3
JournalLung Cancer
Volume130
DOIs
Publication statusPublished - Apr 2019

Keywords

  • Pemetrexed
  • Non-small cell lung cancer
  • Renal impairment
  • Pharmacokinetics
  • CANCER

Cite this